How testosterone replacement therapy injections can boost your mood

In men with persistent symptoms of hypogonadism and testosterone confirmed low on repeat morning testing, testosterone replacement therapy injections that restore levels to the mid-normal range can modestly improve mood and depressive symptoms. Trials show no clear benefit for energy or vitality, and the effect on mood is too small to replace depression treatment.

Key takeaways

• In men with symptomatic hypogonadism, testosterone replacement therapy injections that restore levels to the mid-normal range can modestly improve mood and reduce depressive symptoms. They have not been shown to improve vitality or energy, and they are not a standalone cure for depression.
• Benefit is most likely when persistent symptoms line up with testosterone that is low on repeated morning testing. Diagnosis requires both symptoms and low labs, not just one or the other.
• Common injectable forms (testosterone cypionate or enanthate) are esterified, time-release preparations that slowly convert to bioidentical testosterone over several days after deep intramuscular injection.
• Testosterone acts on androgen receptors in brain regions involved in emotion and memory, such as the amygdala and hippocampus. Exactly how this changes mood in men is not well established.
• A practical approach is two morning panels drawn between 07:00 and 11:00 that include total testosterone, free testosterone, LH and FSH, plus estradiol, CBC, CMP and PSA when indicated, along with checks for conditions that mimic low testosterone (thyroid disease, anemia, depression, sleep apnea). If treatment starts, weekly dosing produces smaller hormone swings than larger doses every two weeks, and labs are checked at baseline, about 3 months after starting or a dose change, then every 6 to 12 months once stable.

The relationship

Testosterone is an androgen, a sex hormone that drives male traits like facial hair, a deeper voice, muscle growth and sperm production. It also acts on brain regions involved in motivation and emotion.

On average, testosterone declines with age in population studies, but individual trajectories vary and much of the drop is associated with health factors such as obesity and chronic disease. The 2018 Endocrine Society guideline recommends diagnosing hypogonadism only in men who have symptoms and signs of testosterone deficiency together with unequivocally and consistently low serum testosterone, confirmed by repeating a fasting morning measurement.^[1]

Testosterone replacement therapy injections supply the same hormone the testes normally make. According to a 2019 systematic review and meta-analysis in JAMA Psychiatry, which pooled 27 randomized placebo-controlled trials in 1,890 men, testosterone treatment was associated with a small but significant reduction in depressive symptoms compared with placebo, with larger effects in trials that used higher doses.^[2] The trials included both hypogonadal and eugonadal men and several forms of testosterone, so the result is not specific to injections.^[2] In the Testosterone Trials, published in the New England Journal of Medicine in 2016, 790 men aged 65 or older with total testosterone below 275 ng/dL and symptoms of low testosterone used testosterone gel or placebo for one year.^[3] Men on testosterone reported slightly better mood and lower severity of depressive symptoms, but there was no benefit for vitality as measured by a fatigue scale.^[3]

How it works

Testosterone replacement therapy injections aim to correct hypogonadism, which means the testes do not make enough testosterone for the body’s needs. The Endocrine Society guideline suggests aiming for testosterone concentrations in the mid-normal range during treatment.^[1]

Diagnosis comes before treatment and rests on persistent symptoms plus repeat morning testing. The same guideline recommends confirming a low result with a second fasting morning total testosterone, and measuring free testosterone by equilibrium dialysis or an accurate formula when total testosterone is near the lower limit of normal or a condition alters sex hormone-binding globulin.^[1]

Injecting testosterone and how it gets into your system

Most testosterone replacement therapy injections use testosterone cypionate or testosterone enanthate. These are esterified forms of testosterone. An ester is a chemical tail that slows release from the muscle into the blood.

The medication is given deep into a muscle, often the glute or thigh. From there, enzymes slowly cleave off the ester, releasing bioidentical testosterone into circulation over several days.

Steadying hormone levels to steady mood

The Endocrine Society guideline lists typical cypionate or enanthate doses of 75 to 100 mg weekly or 150 to 200 mg every two weeks, and notes that these injections produce peaks and troughs in serum testosterone.^[1] Some men notice these swings as changes in mood, energy or libido across the dosing cycle, and splitting the same weekly amount into smaller, more frequent doses narrows the gap between peak and trough. The 2018 AUA guideline recommends monitoring on treatment to confirm that therapeutic testosterone levels are reached and symptoms improve, with a total testosterone target of 450 to 600 ng/dL.^[4]

Talking to brain chemistry

Androgen receptors are present in brain regions involved in emotion regulation and memory, including the amygdala and hippocampus, and testosterone is also converted to estradiol in the brain. These pathways may explain part of its effect on mood, but the mechanisms in men are not well established.

In the JAMA Psychiatry meta-analysis, men on testosterone were more likely than men on placebo to have their depression scores fall by half or more (odds ratio 2.30), and dropout rates did not differ significantly from placebo.^[2] The included trials varied widely, and the authors called for preregistered trials with depression as the primary end point.^[2] In the Testosterone Trials, men on testosterone also reported more sexual activity, greater sexual desire and better erectile function than men on placebo.^[3]

Impact on body composition and energy

Testosterone promotes muscle protein synthesis. A 2016 meta-analysis of 32 observational studies in 4,513 men with testosterone deficiency, published in the Journal of Endocrinological Investigation, found that testosterone treatment was associated with less fat mass, more lean mass and time-dependent reductions in body weight and waist circumference, estimated at about 3.5 kg and 6.2 cm at 24 months.^[5] Because the studies were observational, the authors called for a randomized trial to confirm the weight loss.^[5]

Physical function gains are less certain. In the Testosterone Trials, the share of men whose six-minute walking distance rose by at least 50 meters did not differ significantly from placebo within the physical function trial, though it did when men from all three trials were pooled (20.5% vs 12.6%).^[3]

Risks, side effects, and the role of estrogen

Some injected testosterone is converted into estradiol, a form of estrogen. In men, estradiol supports bone health and sexual function. Too little estradiol can contribute to low sex drive and bone loss, while too much can cause breast tenderness or swelling.

Common side effects of testosterone replacement therapy injections include acne, oily skin, elevated hematocrit (the share of blood made up of red cells), reduced sperm production and fluid retention. In TRAVERSE, a 2023 New England Journal of Medicine trial of 5,246 men aged 45 to 80 with hypogonadism and existing or high risk of cardiovascular disease, testosterone gel was noninferior to placebo for major adverse cardiac events over a mean follow-up of 33 months, although atrial fibrillation, acute kidney injury and pulmonary embolism were more frequent in the testosterone group.^[6] The trial used daily testosterone gel rather than injections.^[6] The Endocrine Society guideline recommends measuring hematocrit as part of routine monitoring, and older men or men with heart disease need careful follow-up.^[1]

Conditions linked to it

Testosterone injections are meant to treat confirmed hypogonadism, not to raise normal levels. The Endocrine Society guideline recommends testosterone therapy for men with symptomatic testosterone deficiency after a discussion of benefits, risks and monitoring, and recommends further evaluation to find the cause of the deficiency.^[1]

Luteinizing hormone (LH) and follicle-stimulating hormone (FSH) show whether the problem starts in the testes or in the brain, and that distinction shapes treatment choices, especially when fertility matters.

• Primary hypogonadism: The testes themselves are failing, often from genetic conditions, infection, trauma or chemotherapy. Blood tests show low testosterone with high LH and FSH, meaning the brain is signaling but the testes cannot respond well. Because the testes cannot be stimulated into making more, this is the clearest situation for testosterone therapy.
• Secondary hypogonadism: The hypothalamus or pituitary gland under-signals the testes. Causes include pituitary tumors, head injuries, certain medications such as opioids, and severe obesity or sleep apnea. Blood tests typically show low testosterone with low or inappropriately normal LH and FSH. Because injected testosterone suppresses sperm production, men in this group who want to preserve fertility may consider treatments that stimulate the body’s own production. Enclomiphene, which raises LH and FSH by blocking estrogen feedback at the hypothalamus, is one such option.
• Functional hypogonadism in midlife or later: Many men who seem to have “age-related” low testosterone have reversible contributors such as obesity, sleep apnea, chronic illness, alcohol use, overtraining or medication effects. LH and FSH are usually low or inappropriately normal, and addressing these contributors is a reasonable first step. Treatment still depends on persistent symptoms plus low values on repeat testing.
• Delayed puberty in adolescent males: Short-term, carefully supervised testosterone injections can start puberty under specialist care.

The Endocrine Society guideline recommends against starting testosterone in men planning fertility in the near term, and in men with breast or prostate cancer, a palpable prostate nodule, PSA above 4 ng/mL (or above 3 ng/mL in higher-risk men) without urological evaluation, elevated hematocrit, untreated severe obstructive sleep apnea, severe lower urinary tract symptoms, uncontrolled heart failure, a heart attack or stroke within the past 6 months, or thrombophilia.^[1]

In men with borderline levels or a history of depression, anxiety or burnout, it can be hard to tell which symptoms come from low testosterone. Depression needs its own assessment and treatment, and testosterone is not a substitute for it. When treatment is tried in these men, close follow-up shows whether symptoms actually change.

Symptoms and signals

Symptoms of low testosterone are often slow and subtle, and many overlap with stress, poor sleep or overwork. The Endocrine Society guideline treats reduced sexual desire, fewer spontaneous erections and erectile dysfunction as more specific to testosterone deficiency, and lists low energy and motivation, depressed mood, poor concentration and reduced muscle strength as less specific.^[1]

Signals that might prompt a conversation about testosterone replacement therapy injections include:

• Low or fading sex drive that persists for months
• Fewer morning erections than in the past
• Difficulty achieving or maintaining erections despite interest
• Unusual fatigue even after decent sleep
• Noticeable drop in motivation, drive or competitiveness at work or in hobbies
• Low mood, irritability or a “flat” emotional state without clear cause
• Loss of muscle mass or strength despite regular activity
• Increase in belly fat or overall body fat
• Reduced shaving frequency due to slower beard growth
• Decreased stamina during exercise or everyday tasks like climbing stairs
• Difficulty concentrating, “brain fog,” or slower mental sharpness
• Lower bone density or fractures from minor falls

None of these symptoms proves that testosterone is the problem. When several cluster together alongside low blood levels on repeat morning tests, testosterone treatment becomes a reasonable topic to discuss.

What to do about it

1. Step 1: Get properly tested
   Ask your clinician for two morning panels, drawn between 07:00 and 11:00, that include total testosterone, free testosterone, LH and FSH, plus estradiol, CBC, CMP and PSA when indicated. The Endocrine Society guideline recommends confirming low testosterone with a repeat fasting morning measurement and adding free testosterone when total testosterone is borderline.^[1] Diagnosis requires persistent symptoms as well as low labs. Your clinician should also check for thyroid disease, anemia, vitamin deficiencies, depression and sleep apnea, which can mimic low testosterone.
2. Step 2: Fix fundamentals and weigh treatment options
   Better sleep, less alcohol, weight loss and resistance training can raise testosterone modestly and help mood on their own. If symptoms persist and labs remain low, discuss treatment options with your clinician. If fertility matters, testosterone therapy is not appropriate, and options that stimulate the testes, such as enclomiphene, can be discussed. When testosterone therapy is indicated, injections are usually the least expensive form, but gels, patches, or pellets may suit some men better.
3. Step 3: Start low, monitor, and adjust
   If you and your clinician choose testosterone injections, dosing is typically weekly or every two weeks and is adjusted based on symptoms and appropriately timed blood levels. The 2018 AUA guideline recommends rechecking total testosterone after starting therapy to confirm the target is reached, then every 6 to 12 months while on treatment.^[4] A common schedule is baseline labs, repeat testing about 3 months after starting or changing dose, then every 6 to 12 months once stable. The Endocrine Society guideline recommends a standardized monitoring plan that reviews symptoms, side effects and adherence, measures testosterone and hematocrit, and evaluates prostate cancer risk during the first year of treatment.^[1] Blood pressure is usually checked as well, and estradiol when symptoms suggest an imbalance.

Veedma offers testing that includes total and free testosterone measured by LC-MS/MS with LH and FSH, or a review of lab results you already have. In Veedma’s protocol, licensed providers treat secondary or functional hypogonadism with enclomiphene, or the enclomiphene plus tadalafil tablet when appropriate, rather than testosterone injections. Enclomiphene is not an FDA-approved drug; it is prescribed after a provider confirms the diagnosis and is compounded by a licensed U.S. pharmacy.

Myth vs fact

Myth: Testosterone replacement therapy injections are just legal steroids for muscle building.

Fact: Medical TRT aims to restore normal levels in men who are low, not to push levels into bodybuilding ranges.

When dosing targets physiological ranges and monitoring is done correctly, the goal is improved health, function and symptoms, not extreme physique changes.

Myth: Once you start injections, you can never stop.

Fact: Some men with reversible causes of low testosterone can taper off under medical guidance.

For men with permanent testicular or pituitary damage, long-term treatment may be appropriate, but it is still a shared decision that can be revisited.

Myth: TRT will fix depression by itself.

Fact: Testosterone can modestly improve mood in men with true hypogonadism, but it does not replace psychotherapy, lifestyle changes or, when needed, antidepressant medication.

When low testosterone is clearly part of the problem, treating it can be one part of a broader mental health plan.

Myth: TRT causes prostate cancer.

Fact: Current evidence does not show that physiological replacement doses increase prostate cancer risk, but testosterone can stimulate growth of existing cancer.

That is why appropriate screening, shared decision-making and ongoing monitoring matter, especially in higher-risk men.

Myth: If a little testosterone helps, more is always better.

Fact: Overshooting into high ranges increases risks such as thickened blood, worsened sleep apnea, mood swings and infertility.

Steady levels in the mid-normal range are the target of medical therapy.

Bottom line

Testosterone replacement therapy injections can modestly improve mood and depressive symptoms in some men with persistent symptoms and testosterone confirmed low on repeat morning testing. They have not been shown to improve vitality and are not a cure for depression. Proper diagnosis, including LH and FSH, and ongoing monitoring, especially early after starting and after dose changes, are essential.

References

1. Bhasin S, Brito JP, Cunningham GR, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018;103:1715-1744. PMID: 29562364
2. Walther A, Breidenstein J, Miller R. Association of Testosterone Treatment With Alleviation of Depressive Symptoms in Men: A Systematic Review and Meta-analysis. JAMA Psychiatry. 2019;76:31-40. PMID: 30427999
3. Snyder PJ, Bhasin S, Cunningham GR, et al. Effects of Testosterone Treatment in Older Men. N Engl J Med. 2016;374:611-24. PMID: 26886521
4. Mulhall JP, Trost LW, Brannigan RE, et al. Evaluation and Management of Testosterone Deficiency: AUA Guideline. J Urol. 2018;200:423-432. PMID: 29601923
5. Corona G, Giagulli VA, Maseroli E, et al. Testosterone supplementation and body composition: results from a meta-analysis of observational studies. J Endocrinol Invest. 2016;39:967-81. PMID: 27241317
6. Lincoff AM, Bhasin S, Flevaris P, et al. Cardiovascular Safety of Testosterone-Replacement Therapy. N Engl J Med. 2023;389:107-117. PMID: 37326322